Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials. | J Rheumatol | 2010 | 1.91 |
2 | Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. | N Engl J Med | 2015 | 1.28 |